Q4 2017 Holdings
Filed 2018-02-14 | 72 holdings | $34.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.3K | 361,164 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.7K | 39,609 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.8K | $4,000,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.8K | 983,478 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $4.0K | 346,013 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.2K | 54,508 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $4.3K | 998,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.7K | 28,800 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.8K | 83,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.9K | 304,000 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $5.2K | 216,119 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $5.4K | 134,147 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $7.0K | 116,770 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.6K | 100,691 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $24.9K | 296,000 | 0.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.8M | 275,059 | 5.3% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.0M | 135,738 | 5.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.0M | 124,639 | 14.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.9M | 1,193,228 | 17.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $6.0M | 61,349 | 17.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.0M | 95,396 | 17.7% |
| Atricure Inc(ATRC) | COM | 04963C209 | $7.1M | 389,145 | 20.9% |